Symbol="CGEM"
AssetType="Common Stock"
Name="Cullinan Oncology LLC"
Description="Cullinan Management, Inc., a biopharmaceutical company, is focused on developing a line of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company is headquartered in Cambridge, Massachusetts."
CIK="1789972"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="ONE MAIN STREET, SUITE 520, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="442303000"
EBITDA="-162514000"
PERatio="None"
PEGRatio="None"
BookValue="11.69"
DividendPerShare="0"
DividendYield="0"
EPS="-3.46"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.171"
ReturnOnEquityTTM="-0.258"
RevenueTTM="0"
GrossProfitTTM="18943000"
DilutedEPSTTM="-3.46"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="25.25"
TrailingPE="-"
ForwardPE="6.3"
PriceToSalesRatioTTM="26.88"
PriceToBookRatio="0.91"
EVToRevenue="11.55"
EVToEBITDA="0.284"
Beta="0.154"
num_52WeekHigh="14.04"
num_52WeekLow="7.78"
num_50DayMovingAverage="10.74"
num_200DayMovingAverage="10.92"
SharesOutstanding="42734600"
DividendDate="None"
ExDividendDate="None"
symbol="CGEM"
open="10.89"
high="10.89"
low="10.32"
price="10.35"
volume="237588.00"
latest_trading_day="2023-08-31"
previous_close="10.89"
change="-0.54"
change_percent="-4.9587%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="44"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="56"
Volume_recent_avg="261507"
Change_recent_avg="0.01"
Delta_recent_avg="0.58"
Variance_recent_avg="0.29"
Change_ratio_recent_avg="0.04"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="56"
Aroon_momentum_negative="44"
image_negative_thumbnail_id_1="108"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0068.jpeg"
image_negative_thumbnail_id_2="98"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0078.jpeg"
image_neutral_thumbnail_id_1="537"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0062.jpeg"
image_neutral_thumbnail_id_2="527"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_positive_thumbnail_id_1="979"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0141.jpeg"
image_positive_thumbnail_id_2="660"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0048.jpeg"
image_professor_thumbnail_id_1="1167"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
